CASE Issues Statement & Letter to Senate on Danger of Democrats’ Latest Drug Pricing Plan
July 21, 2022 Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement and...
July 21, 2022 Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement and...
July 6, 2022 After months and months of petty negotiations over Build Back Better, Democrats have finalized a dangerous...
May 12, 2022 A well-intentioned but ineffective proposal that would force drug manufacturers to post the price of prescription...
May 11, 2022 Dear Senate Leaders, In spite of well-founded fears about the safety and effectiveness of allowing states to...
March 16, 2022 A thief never returns to the scene of the crime, the saying goes. But like many...
February 28, 2022 Mark Cuban is making headlines, and not for the reason you’d think. The billionaire investor seized...
December 6, 2021 Statement from Consumer Action for a Strong Economy (CASE) strongly opposing continued efforts by the White House...
November 5, 2021 Leaders on Capitol Hill are making a last-ditch effort to include price controls in the social...
September 9, 2021 The Biden administration recently announced its plan to “lower prescription-drug prices” by way of Medicare negotiation—but...
April 21, 2021 CASE Statement: As a leading advocate for consumers and patients across the country, Consumer Action for a...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers